NDC 63629-7413-01 - Ezetimibe
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-7413
- Requested NDC
- 63629-7413-01
- Package NDCs from labels
- 63629-7413-1, 63629-7413-2, 63629-7413-3, 63629-7413-4, 63629-7413-5, 63629-7413-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-04-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ezetimibe - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-04-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-7413-1 | Ezetimibe | 30 in 1 BOTTLE | TABLET | 30 | 4 | |
| 63629-7413-2 | Ezetimibe | 90 in 1 BOTTLE | TABLET | 90 | 4 | |
| 63629-7413-3 | Ezetimibe | 28 in 1 BOTTLE | TABLET | 28 | 4 | |
| 63629-7413-4 | Ezetimibe | 18 in 1 BOTTLE | TABLET | 18 | 4 | |
| 63629-7413-5 | Ezetimibe | 60 in 1 BOTTLE | TABLET | 60 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-7413 | EZETIMIBE TABLET [BRYANT RANCH PREPACK] | 4 | Current NDC, Legacy NDC, 5 package rows | 20240518_03609879-bad2-4e75-83fe-1e1a2fd300c3.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ezetimibe | EZETIMIBE | Ascend Laboratories, LLC | 206d702c-b09a-4555-972b-6555d6d6d6e6 | 2025-06-13 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Bryant Ranch Prepack | 3a80b668-51cd-42be-8497-8712b0508422 | 2025-05-12 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe and Simvastatin | EZETIMIBE AND SIMVASTATIN | Ascend Laboratories, LLC | c90e8c96-e130-42d7-bf0d-5833652e40d5 | 2025-05-02 | Warnings, Adverse reactions | EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Aurobindo Pharma Limited | 726b1e63-437a-4b3b-b773-3ac47a5c0f38 | 2025-03-13 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | NorthStar Rx LLC | 5f5644a9-e019-4e5d-ab6f-3d30b1024c5a | 2025-03-13 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Proficient Rx LP | 55b18d8f-40e0-48ba-baf1-79a0d1bb2ee2 | 2025-03-01 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Ezetimibe | EZETIMIBE | Amneal Pharmaceuticals NY LLC | 3fadf4e9-017d-4ccd-91dc-a89b981eb138 | 2025-02-10 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUM | Energique, Inc. | f3db63df-62a4-48d6-92e7-94e4a5701552 | 2024-12-20 | Warnings | 368GB5141J |
| ezetimibe | EZETIMIBE | Zydus Lifesciences Limited | de814dcd-4759-4e9c-a650-335fb885a79d | 2024-11-28 | 349556 EOR26LQQ24 | |
| Ezetimibe and Simvastatin | EZETIMIBE AND SIMVASTATIN | Aurobindo Pharma Limited | 79dadfde-35c7-4937-9c82-1728fb6be2fb | 2024-10-22 | Warnings, Adverse reactions | EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 5877150f-2807-435e-8e5b-a07dc7dbfd27 | 2024-10-21 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 1afdb764-c5da-4982-beae-9be61bdcbcdc | 2024-10-21 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 63ecbbf1-a6de-493f-9710-812ff45cb4d3 | 2024-09-29 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | Energique, Inc. | 87c92497-8a51-4977-87fe-e0b4c6bafb19 | 2024-09-27 | Warnings | 368GB5141J |
| Ezetimibe | EZETIMIBE | Glenmark Pharmaceuticals Inc., USA | ac539a72-77e4-419c-b1d9-42002e9cecf7 | 2024-07-31 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| EZETIMIBE | EZETIMIBE | Camber Pharmaceuticals, Inc. | c07fe2e0-dad4-48b5-8a07-7d57a4035ccd | 2024-07-19 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Bryant Ranch Prepack | d6b4fd12-9954-42ba-b42a-56f3747c47ff | 2024-07-09 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | ScieGen Pharmaceuticals Inc | 11de499b-ad8a-46a6-9021-c8eba72ae414 | 2024-06-12 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Macleods Pharmaceuticals Limited | ebe3fa4e-82c4-4a9a-9aec-f64019391f4e | 2024-05-13 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.